Join BOPA
Back to news articles

Community Approach to Supporting People with Advanced Cancer (CASPC)

By BOPA Executive Committee on 2nd March 2026

Community Approach to Supporting People with Advanced Cancer (CASPC)

INVITATION TO ATTEND A WORKSHOP EXPLORING SUPPORT FOR PATIENTS WITH ADVANCED CANCER IN PRIMARY CARE

Thursday April 23rd 2026 5.30pm to 8pm

CASPC is a multi-professional special interest group affiliated with the British Oncology Pharmacy Association (BOPA) & the United Kingdom Oncology Nursing Society (UKONS)

The workshop will be led by Dr Barry Quinn, Senior Lecturer in Cancer Care, Queen’s University Belfast & Dr Jackie Lewis, Community Pharmacist with an interest in cancer.

The Patterson Building, The Christie Hospital Manchester

Travel expenses and buffet food will be provided.

RSVP [email protected]

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article